The company is obviously gearing for recreational cannabis.

I think this comparison is flawed. Cgc is definitely showing investment into "high tech" intellectual property and research. Plus, this is probably more a kin to a pharmaceutical rather than a commodity at it's core, which isn't simply a race to the bottom in terms of price.

I think if you consider the increase in sheer business activity and execution with the merger, MT holders are at a large advantage: several international collaborations, diversified research and potential intellectual property, a large scale greenhouse, increased indoor production space and increased capital (potential through an increased stock price and liquid cash on hand) to mention a few.

I'm not sure why anyone would stop this merger - speaking of which, what's the source that MT shareholders are generally against this merge? One guy on this board?

Agreed. They'll be too much money moving around to ignore the sector.

I wonder if they intended their company symbol to look like the universal symbol for a biohazard....

These are all speculative statements. There are lots of examples where a company is valued at more than it is making.

In reality, no one truly knows where this is headed -technical metrics or not considered.

Stick to the facts - the cannabis market is projected to be huge and internationally reaching and because of this, I'm willing to bet this company will be more in the future than it is today.

I think something unseen and fatal for the company would have to happen for me to offer up my shares.

Haha, fair enough, it does fit the curve nicely but I'm sure you can find that pattern all over the place where it does not result in a bubble.

Long-term in an emerging, multi billion dollar industry, this seems like it has some legs.

Not you, someone was saying it was dropping in a bubble and cited a reddit thread. I just grabbed your message as the reply, since you the most recent comment on the same suggestion.

I've been here since the IPO as a lurker.

I dare you to sell your shares and/or short it then if you truly think this is such a bubble situation. I dare you.

The projected market is huge - fact. This company is well positioned to take a large piece of that pie - fact.

I'd be worried if this company were in line for a license and only were claiming they were going to execute a cannabis-based business plan, but they're not. CGC is executing.

I love when you look around that subreddit thread and see others pushing lower companies. They may hit big, but I think the risk here in CGC is much less and that's why you pay more for a less risky investment in the cannabis industry.

Could cannabis be the solution to our opioid crisis to treat pain?

http://www.cbc.ca/news/politics/opioid-conference-british-columbia-ottawa-1.3855162

The science agrees with this; cannabis is relatively safe, efficacious in the treatment of pain and inflammation, and is not physiologically addiction - consider a shift in the way health care manages pain and what that would do for this industry.

Yup - plant breeder rights and patents will be the routes to protect intellectual property.

In terms of the strength of these findings and their ability to protect them, there are a lot of broad patents held in the USA, making it more difficult to protect some cannabinoid-based medicines, but it is definitely possible.

These are long term goals that can be very expensive, as all research is, but if they hit, they can be very important.

This is only a recommendation. It will then be on the government to heed this expert advice and craft rules with this.

Hopefully they don't play politics too hard and actually listen to the experts - our previous government never did the latter very well in my opinion.

All in all, I don't predict this task force report to be a huge game changer, but I suspect it will begin to take some of the guess work and speculation out of what the recreational market will really look like and solidify LPs in this process.


I think it'll open the doors for some new, derivative products in the process.

I speculate we will see a further commitment to regulated, rigorously tested and controlled production (no duh!), which favours the LP style that is established versus previous growing methods and gives LPs the nod to move forward.

We should also hope to see the rules about age included for recreational consumption and maybe recommendations on how much one can carry, personally produce and where genetics can be sourced/purchased from. Also, rules about driving while under the influence and where an individual can consume these products may be included.

I think we will also see derivatives being included in the legal model, with more clarification on the laws surrounding these products, including topicals, oil and fresh leaf products.

I think we will see a clarification on what is ok in terms of a store front and company's ability to market their products.

All this being said, it's also possible that many of these details are left to the province to come up with.

Someone also mentioned insurance coverage - I think this will be up to the individual companies to sort out. If a drug identification number (DIN) is given to medical cannabis, then this will this possibility more mainstream, but some companies are already covering it, such as Sunlife.

Meh, it was due for a pull back

No doubt. Release confirms this, actually.

A bunch of industry stocks are halted. It's probably those making money and the way up and shorting it down hard - crazy.

That's ok, this need a pull back.

Acb halted for a moment too on the a big blast up - what's up with that?

Is it the exchange trying to slow things down a bit?

On a side note, ACB was halted momentarily as it hit a crazy swing up - any reason why that might happen?

Do they halt on the way up if it is too extreme on the venuture, or something?

I can't work right now.... all I can do it watch this thing climb

15.91 - this is a farce

15.65...

The long term for this stock is pretty bright when you consider the market estimates.

Personally, I wouldn't try flipping it for some moderate gains, but to each their own.

Canada has been growing hemp for several years now and has had an advantage over the states, who only recently started allowing hemp-based agricultural activity to start up again.

The regulations are governed by Health Canada and they are less cumbersome than cannabis with THC>0.3%, but they are still a major barrier to production.

As mentioned, no one in their right mind would try to make a profit growing hemp indoors.

Hemp is currently used as fibre, seed and oil (non-THC laden) - lobby groups are actively trying to allow CBD collection to occur for hemp farmers as an alternative revenue source for farmers, and researchers are actively looking into cannabinoid levels (other than THC) in the legal hemp seed stocks that farmers are allowed to grow.

What are you even saying? It's a good thing plebs aren't writing these new laws because it would be even more of a mess than it is.

Healthcare is paid for by provincial and federally collected taxes.....

No money is collected and recirculated into our Healthcare system. It's all paid for by government revenue or private insurance companies that collect money from the users in some form.

Do you think pharmacies are putting their profits back into the healthcare system?

You might be right but pain killers are covered by insurance, where medical cannabis isn't, and this raises the prices to patients.

But this doesn't really reflect the reality. There are undoubtably issues with the current MMPR frame work that they hopefully improve on.

Because the oil isn't alive, I don't think it can be considered a biological.

FYI:
http://www.theglobeandmail.com/news/national/shoppers-drug-mart-shows-budding-interest-in-selling-medical-pot/article28863445/

Feeding frenzy right before the financials?

CGC is going ham.

You mean investor's dollars. Sale to patients hasn't even come close to the amount of investment thus far....

I need to stop feeding the trolls...

I think this boost will be transient off the news of snoop. The media exposure is great, but I think the mainstream hasn't seen much since this deal. Oils together with positive financials will be more sustainable upward pressure.

Someone already asked, but I'm going to reiterate - when do the fins come out?

I own no shares of SL, but you really can't see what business they're in?

They're stock price reflects the risk and uncertainty involved - it's simple. The company may be overvalued, but they do have tangible assets such as their greenhouse/facility, plus they are quite far along in the Health Canada licensing process.

You're basically arguing that no one should invest anywhere else but CGC, which is pretty obviously bias. Hey, that will help me out, but your bias and bashing is a little hard to listen to sometimes. With your logic, no one should ever invest in a start up or any business that isn't established - come on...

This is investing - you can speculate all you want but in reality much of this is semi-informed luck.

http://www.bnn.ca/Shows/Commodities.aspx

They're talking about the literature surrounding the growing. They do know a bit about the genetics that guide CBD and THC production. It's actually pretty straight forward and the metabolic synthesis pathways involved are very well hammered out. Plus, the cannabis genome has been sequenced a few years back and people have moved beyond the main cannabinoids are now looking at the genes and pathways that control terpene production - I'd argue they do know a lot about the plant.

Ew, this was their master grower? Maybe she should stick to growing and leave the literature to someone else.

Edit: after looking at their team (http://www.tilray.com/home/#experts). their best bet would be the clinical research director. I sure hope they aren't describing cannabis as a therapeutic that way.

Saying cannabis is therapeutically relevant is folklore is pretty degrading. I think it's better described as having tons of anecdotal evidence with no large sample, double blinded studies being conducted on it thus far. There is a study going on now evaluating cannabis as a treatment in chronic arthritis of the knee out East, I believe.

Besides that, there is also a lot of basic science, ranging from cell culture, to large mammalian model systems, showing various cannabinoids are useful for a whole host of applications, including brain injury, cancer, chronic pain, inflammation and nausea. I find this is often over looked, maybe because it's hard for non-experts to wrap their heads around it.

If we were to find cannabis today and it didn't carry decades of sigma, we'd be rushing it's evaluation as a therapeutic, trying to understand it's mechanism of action and be taking a detailed look at the 100's of cannabinoids that cannabis makes.

So are you just fishing for a high-five and a gold star?

What's there to get? That crying because there's going to be a change to the current, very grey market system on an investor board gets you no sympathy?

Go lobby like everyone else in a rational and well thought out manner.